UMMS Affiliation

Department of Pediatrics; Program in Molecular Medicine

Publication Date


Document Type



Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Disease Transmission, Vertical; Drug Therapy, Combination; HIV Antibodies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lymphocyte Activation; RNA, Viral; Reverse Transcriptase Inhibitors; T-Lymphocytes, Cytotoxic; Viral Load; Virus Replication


Life Sciences | Medicine and Health Sciences


Studies of potent antiretroviral combination regimens were undertaken in young infants to evaluate the potential for long-term suppression of viral replication and to evaluate the immune consequences of such therapies. Early combination antiretroviral therapy led to a loss of plasma viremia, cultivable virus, and labile extrachromosomal replication intermediates. Despite preservation of immune function, persistent human immunodeficiency type 1 (HIV-1)-specific immune responses were not detected in most infants. The absence of detectable, persisting immune responses in most HIV-1-infected infants treated early contrasts with what is typically seen in adults who are treated early. These results are consistent with the notion that early combination antiretroviral therapy of HIV-1-infected infants allows the long-term suppression of viral replication.

Rights and Permissions

Citation: J Virol. 2000 Aug;74(15):6984-91.

Related Resources

Link to Article in PubMed

Journal/Book/Conference Title

Journal of virology

PubMed ID




To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.